Crescita Therapeutics Stock Market Value
| CTX Stock | CAD 0.47 0.02 4.08% |
| Symbol | Crescita |
Crescita Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Crescita Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Crescita Therapeutics.
| 11/16/2025 |
| 02/14/2026 |
If you would invest 0.00 in Crescita Therapeutics on November 16, 2025 and sell it all today you would earn a total of 0.00 from holding Crescita Therapeutics or generate 0.0% return on investment in Crescita Therapeutics over 90 days. Crescita Therapeutics is related to or competes with Delivra Health, and Avant Brands. Crescita Therapeutics Inc., a dermatology company, provides non-prescription skincare products and prescription drug pro... More
Crescita Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Crescita Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Crescita Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.87 | |||
| Information Ratio | (0.02) | |||
| Maximum Drawdown | 13.14 | |||
| Value At Risk | (4.55) | |||
| Potential Upside | 4.26 |
Crescita Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Crescita Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Crescita Therapeutics' standard deviation. In reality, there are many statistical measures that can use Crescita Therapeutics historical prices to predict the future Crescita Therapeutics' volatility.| Risk Adjusted Performance | 0.0085 | |||
| Jensen Alpha | 7.0E-4 | |||
| Total Risk Alpha | (0.21) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.0523 |
Crescita Therapeutics February 14, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0085 | |||
| Market Risk Adjusted Performance | 0.0623 | |||
| Mean Deviation | 1.7 | |||
| Semi Deviation | 2.51 | |||
| Downside Deviation | 4.87 | |||
| Coefficient Of Variation | 55320.48 | |||
| Standard Deviation | 2.72 | |||
| Variance | 7.38 | |||
| Information Ratio | (0.02) | |||
| Jensen Alpha | 7.0E-4 | |||
| Total Risk Alpha | (0.21) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.0523 | |||
| Maximum Drawdown | 13.14 | |||
| Value At Risk | (4.55) | |||
| Potential Upside | 4.26 | |||
| Downside Variance | 23.72 | |||
| Semi Variance | 6.32 | |||
| Expected Short fall | (2.82) | |||
| Skewness | (0.66) | |||
| Kurtosis | 1.63 |
Crescita Therapeutics Backtested Returns
As of now, Crescita Stock is abnormally volatile. Crescita Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0263, which signifies that the company had a 0.0263 % return per unit of standard deviation over the last 3 months. We have found twenty-nine technical indicators for Crescita Therapeutics, which you can use to evaluate the volatility of the firm. Please confirm Crescita Therapeutics' risk adjusted performance of 0.0085, and Mean Deviation of 1.7 to double-check if the risk estimate we provide is consistent with the expected return of 0.0718%. Crescita Therapeutics has a performance score of 2 on a scale of 0 to 100. The firm shows a Beta (market volatility) of -0.0973, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Crescita Therapeutics are expected to decrease at a much lower rate. During the bear market, Crescita Therapeutics is likely to outperform the market. Crescita Therapeutics right now shows a risk of 2.73%. Please confirm Crescita Therapeutics potential upside, rate of daily change, and the relationship between the sortino ratio and skewness , to decide if Crescita Therapeutics will be following its price patterns.
Auto-correlation | -0.05 |
Very weak reverse predictability
Crescita Therapeutics has very weak reverse predictability. Overlapping area represents the amount of predictability between Crescita Therapeutics time series from 16th of November 2025 to 31st of December 2025 and 31st of December 2025 to 14th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Crescita Therapeutics price movement. The serial correlation of -0.05 indicates that only as little as 5.0% of current Crescita Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.05 | |
| Spearman Rank Test | 0.05 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Other Information on Investing in Crescita Stock
Crescita Therapeutics financial ratios help investors to determine whether Crescita Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Crescita with respect to the benefits of owning Crescita Therapeutics security.